Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 4/20 | 0.41 |
| ▸ | BLM | P54132 | 4/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.41 |
| ▸ | TP53 | P04637 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.41 |
| ▸ | GMNN | O75496 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | THPO | P40225 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14842937 | 1.00 | ALDH1A1 (0.47) | ALDH1A1ALOX15CYP2D6LMNABLM | |
| Ethylene SCHEMBL11644945 | 0.93 | ALDH1A1 (0.42) | ALDH1A1ALOX15CYP2D6LMNABLM | |
| Ethylene SCHEMBL11644957 | 0.93 | ALDH1A1 (0.42) | ALDH1A1ALOX15CYP2D6LMNABLM | |
| SCHEMBL3977045 | 0.85 | — | — | |
| SCHEMBL293277 | 0.85 | — | — | |
| SCHEMBL293276 | 0.85 | — | — | |
| SCHEMBL8632835 | 0.85 | — | — | |
| SCHEMBL3977043 | 0.85 | — | — | |
| SCHEMBL11937917 | 0.85 | — | — | |
| SCHEMBL4564186 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1813630-B1 | Encapsulated Michael addition catalyst | ROHM & HAAS (US) | 2010-03-03 | — | — | EP | claimed |
| WO-2023093517-A1 | SOLID-STATE ELECTROLYTE AND SECONDARY BATTERY | 深圳新宙邦科技股份有限公司 | 2023-06-01 | — | — | WO | disclosed |
| EP-3281931-A1 | METHODS OF MAKING ORGANIC COMPOUNDS BY METATHESIS | Elevance Renewable Sciences, Inc. (US) | 2018-02-14 | — | — | EP | disclosed |
| US-9481643-B2 | Fluorosurfactants | MERCK PATENT GMBH (DE) | 2016-11-01 | — | — | US | disclosed |
| US-20150246875-A1 | FLUOROSURFACTANTS | MERCK PATENT GMBH (DE) | 2015-09-03 | — | — | US | disclosed |
| EP-2325167-A1 | METHOD FOR PRODUCING CARBAMATE COMPOUND | Ube Industries, Ltd. (JP) | 2011-05-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150246875-A1 | FLUOROSURFACTANTS | FPR3, Q6ZSR9, FLNB | ALDH1A1 2256/4885ALOX15 1804/4885CYP2D6 2941/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.